IPO ChampIPO Insights
IPO Champ LogoIPO Champ Logo

IPOs

IPO Calendar
GMP Tracker
Subscription Status
Allotment Status
Stock Broker
  • Follow us on Instagram
  • Follow us on Facebook
  • Follow us on Threads
  • Follow us on YouTube
  • Follow us on Telegram
  • Follow us on WhatsApp
HomeIPOAvience Biomedicals

About Avience Biomedicals

Incorporatedin June 2024, Avience Biomedicals Limited is an ISO-certified company involved in the manufacture, supply, and export of molecular diagnostics solutions, with an emphasis on biotechnology, genomics, and the IVD sector. Avience Biomedicals Limited has diversified its portfolio of products from IVD rapid test kits to include an extensive range of medical devices such as serology products and biochemistry analyzers. It is committed to addressing varied healthcare needs with a special focus only on the B2B and B2G markets.The products of the company are targeted at Pathology Labs, Microbiology Labs, Hospitals, and Research Centers both in the nation and abroad. Besides being a manufacturer, the Company also acts as a distributor and trader of medical equipment.The company's manufacturing plant is located in Noida, Uttar Pradesh. As of January 31, 2026, the company has 75 permanent employees and 33 contractual employees.

Checklist Quality Analysis

Live IPOs

National Stock Exchange of India logo

National Stock Exchange of India

Mainboard
Open  Close17th Sep 2026 - 21st Sep 2026
Issue Size22561.57 Cr
Min. Qty8 Shares
Issue Price₹ 1700.00
Live IPO
Antala Industries logo

Antala Industries

SME
Open  Close29th Oct 2026 - 5th Nov 2026
Issue Size22.98 Cr
Min. Qty2000 Shares
Issue Price₹ 62.00
Live IPO
Companies NameOpen - CloseIssue SizeMin. QtyIssue PriceApply
National Stock Exchange of India logo

National Stock Exchange of India

Mainboard
17th Sep 2026 - 21st Sep 202622561.57 Cr8 Shares₹ 1700.00
Antala Industries logo

Antala Industries

SME
29th Oct 2026 - 5th Nov 202622.98 Cr2000 Shares₹ 62.00
See All Live IPOs
IPO Champ LogoIPO Champ Logo

IPO Champ helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

Tools

IPO CalendarGMP TrackerSubscription StatusAllotment Status

IPOs

All IPOsLive IPOsUpcoming IPOsClosed IPOsListed IPOs

Resources

NewseBooks

Company

HomeAbout UsPrivacy PolicyTerms of Service

About IPO Champ

IPO Champ is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
help@ipochamp.com.

Please read all offer documents and risk disclosures carefully before investing. IPO Champ does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Champ. All rights reserved.

Want to stay updated?Subscribe to our newsletter

Avience Biomedicals

Avience Biomedicals

Open Date

Jun 18, 2026

Close Date

Jun 22, 2026

listed

Min Investment

₹2,49,600

Lot Size

600 Shares

Issue Size

₹30.24 Cr

Price Range

₹196 - ₹196

Listing Date

Jun 25, 2026

IPO Doc

RHP PDF

Revenue Growth

Company Valuation

Earning Expansion

The investment checklist helps you understand a company's financial health at a glance and identify quality investment opportunities easily.

₹145(+69.71%)GMP
34.86%Prediction Listing Gain

Grey Market Premium (GMP) Trend

Avience Biomedicals IPO - Issue Objectives

The company will use ₹15.96 crore for setting up of a new manufacturing unit. The company will use ₹ 8.25 crore for working capital requirements of business. Part of the IPO proceeds will be used for general corporate purposes and issue expenses

Capital expenditure

52.7%

Working capital

27.2%

General corporate purposes

19.9%

1

Capital expenditure

The company will use ₹15.96 crore for setting up of a new manufacturing unit.

52.70%
2

Working capital

The company will use ₹ 8.25 crore for working capital requirements of business.

27.20%
3

General corporate purposes

Part of the IPO proceeds will be used for general corporate purposes and issue expenses

19.90%

IPO Subscription Status

QIB
196.77x
NII
597.62x
Individual
401.22x
Total
385.33x

Times subscribed by category (bars capped at 10x for readability). Dashed line marks 1.0x (fully subscribed).

Financials of Avience Biomedicals

In Cr.

Contact Details

Avience Biomedicals

C-11, Block-C, Community Centre, Janakpuri A-3, New Delhi - 110058.

18001204636
info@avienbio.com
https://avienbio.com

Avience Biomedicals IPO - FAQs

Avience Biomedicals IPO is a SME IPO. The issue is priced at 196-₹208. The minimum order quantity is 600 Shares. The IPO opens on 18 Jun, and closes on 22 Jun. TBA is the registrar for the IPO. The shares are proposed to be listed on SME.








IPO Timeline

  • Pre Apply2026-06-17
  • Bidding Starts2026-06-18
  • Bidding Ends2026-06-22
  • Allotment Finalisation2026-06-23
  • Release of Funds2026-06-24
  • Demat Transfer2026-06-24
  • Listing2026-06-25